Procalcitonin in paediatric cancer patients: Its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II

British Journal of Haematology

Volumn 111, Issue 4, 2000, Pages 1093-1102

  Fleischhack, Gudrun ^a   Kambeck, Isabell ^a   Cipic, Dubravka ^a   Hasan, Carola ^a   Bode, Udo ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CRP; Febrile neutropenia; Inflammatory cytokines; Inflammatory soluble cytokine receptors; Procalcitonin

Indexed keywords

ANTINEOPLASTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PROCALCITONIN;

ARTICLE; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; FEBRILE NEUTROPENIA; FEMALE; GRAM NEGATIVE INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYREXIA IDIOPATHICA; SCHOOL CHILD;

ADOLESCENT; ADULT; ANTIGENS, CD; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; FEVER; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; INTERLEUKIN-6; INTERLEUKIN-8; MALE; NEOPLASMS; NEUTROPENIA; PROTEIN PRECURSORS; RECEPTORS, INTERLEUKIN-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0034486506     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02458.x     Document Type: Article

References (48)

1. Procalcitonin in patients with and without immunosuppression and sepsis
2. Procalcitonin in diagnosis of severe infections
3. High serum procalcitonin concentrations in patients with sepsis and infection
4. Interleukin-8, a chemotactic and inflammatory cytokine
5. Interleukin-6 and its receptor during homeostasis, inflammation, and tumor growth
6. Serum procalcitonin rise is only slight in two cases of disseminated aspergillosis
7. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults
8. Soluble interleukin-2 receptors in sera of children with primary malignant neoplasms
9. Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells
10. Procalcitonin in pediatrics: Overview and challenge
11. Plasma IL-8 and IL-6 levels can be used to define a group with low risk of septicaemia among cancer patients with fever and neutropenia
12. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: Comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia
13. An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteraemia and complicated infection in neutropenic cancer patients
14. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: Comparison with interleukin-8
15. Monitoring of endotoxin, interleukin-6 and C-reactive protein serum concentrations in neutropenic patients with fever
16. Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis
17. Procalcitonin - A sensitive inflammation marker of febrile episodes in neutropenic chidren with cancer
18. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections
19. Interleukin-8 in sepsis: Relation to shock and inflammatory mediators
20. The influence of surgery on cytokines in patients with intraabdominal sepsis
21. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies
22. Diagnostic markers of infection: Comparison of procalcitonin with C reactive protein and leucocyte count
23. Interleukin-6 and its relationship to C-reactive protein and fever in children with febrile neutropenia
24. Soluble interleukin-2 receptors in pulmonary tuberculosis
25. Correlation of soluble interleukin-2 receptor levels with severity of chronic hepatitis C virus liver injury and development of hepatocellular cancer
26. Clinical applications of C-reactive protein in pediatrics
27. Procalcitonin - A new indicator of the systemic response to severe infections
28. Value of C-reactive protein determination in the initial diagnostic evaluation of the febrile, neutropenic child with cancer
29. Assessment of measuring circulating levels of interleukin-6, interleukin-8, C-reactive protein, soluble Fc gamma receptor type III, and mannose-binding protein in febrile children with cancer and neutropenia
30. Serum cytokine levels after HLA-identical bone marrow transplantation
31. Interleukin-6: A comprehensive review
32. Circulating interleukin-8 concentrations in patients with multiple organ failure of septic and nonseptic origin
33. Outcome prediction by traditional and new markers of inflammation in patients with sepsis
34. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points
35. Altered release of tumor necrosis factor and its soluble receptor in non-Hodgkin's lymphoma patients
36. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis
37. Changes in procalcitonin and interleukin 6 levels among treated African patients with different clinical forms of malaria
38. Soluble interleukin-2 receptor monitoring during bacterial and viral infections in liver transplant recipients: A comparative evaluation
39. Serial monitoring of soluble interleukin-2 receptor as a rapid marker of cytomegalovirus infection and response to antiviral therapy
40. Procalcitonin concentrations in patients with neutropenic fever
41. Procalcitonin and C-reactive protein: Comparison of two markers for sepsis-syndrome in severely immunocompromised children after bone marrow transplantation
42. Procalcitonin: A new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation
43. Increase in interleukin-6 serum level preceding fever in granulocytopenia and correlation with death from sepsis
44. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever
45. New insights into the biology of the acute phase response
46. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia
47. Interleukin 8 in serum in granulocytopenic patients with infections
48. WHO Handbook for reporting results of cancer treatment